Variant position: 96 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1960 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human NPPKFSKVEDMAELTCLNEA SVLHNLKERYYSGLIYTYSGL
Mouse NPPKFSKVEDMAELTCLNEA SVLHNLKERYYSGLIYTYSGL
Rat NPPKFSKVEDMAELTCLNEA SVLHNLKERYYSGLIYTYSGL
Chicken NPPKFSKVEDMAELTCLNEA SVLHNLKERYYSGLIYTYSGL
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
2 – 1960 Myosin-9
81 – 776 Myosin motor
2 – 838 Mediates interaction with LIMCH1
102 – 102 N6-acetyllysine
1 – 136 Missing. In isoform 2.
Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes.
Arrondel C.; Vodovar N.; Knebelmann B.; Gruenfeld J.-P.; Gubler M.-C.; Antignac C.; Heidet L.;
J. Am. Soc. Nephrol. 13:65-74(2002)
Cited for: VARIANTS MATINS LEU-96; LEU-1165; TRP-1400; ASN-1424 AND LYS-1841; TISSUE SPECIFICITY;
Bladder exstrophy and Epstein type congenital macrothrombocytopenia: evidence for a common cause?
Utsch B.; DiFeo A.; Kujat A.; Karle S.; Schuster V.; Lenk H.; Jacobs U.; Mueller M.; Doetsch J.; Rascher W.; Reutter H.; Martignetti J.A.; Ludwig M.; Troebs R.-B.;
Am. J. Med. Genet. A 140:2251-2253(2006)
Cited for: VARIANT MATINS LEU-96;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.